Podcast

Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm

Business of Biotech Podcast

Podcast

CMC Considerations For In-Human Studies with Drs. Edith Perez and Nathan Ihle

Business of Biotech Podcast

Podcast

Randy Schatzman, PhD, CEO of Bolt Biotherapeutics

Biotech 2050 Podcast

Podcast